Harlan Teklad 誘導動物NAFLD and NASH飼料
Teklad diet, bedding and enrichment? ? Teklad laboratory animal diets? ?Custom research diets? ?NAFLD and NASH
誘導嚙齒動物NAFLD/NASH的飲食方法可分為兩大類:
- 長期喂飼可誘發(fā)肥胖、代謝綜合癥及輕微納什或
- 短時間喂飼可誘發(fā)嚴重納什的肝臟特征而不引起肥胖或胰島素抵抗的飲食。
下表突出了上述兩個類別的飲食選擇。有關NAFLD/NASH模型的更完整描述,請參見表后面的下拉菜單。
Dietary methods to induce NAFLD/NASH in rodents can be split into two common categories:
- diets fed for longer periods of time to induce obesity, metabolic syndrome, and mild NASH or
- diets fed for short periods of time to induce hepatic features of severe NASH without inducing obesity or insulin resistance
This page provides further information on dietary methods to induce NAFLD/NASH.?We’ve also prepared a?downloadable?NASH/NAFLD mini paper.
The tables below highlight diet options from both of the above categories. For more complete descriptions of NAFLD/NASH models see the drop down menus that follow the tables.
Diet options for inducing obesity, metabolic syndrome and mild NAFLD/NASH | |||
Diet features | Western/Fast Food | ALIOS | FPC diet |
Product Code | TD.88137 | TD.06303 | TD.160785?PWD?dough
TD.190142?pellet |
Fat, % Kcal | 42 | 45 | 52 |
Fat Sources, % by weight |
21% milk fat | 22%?hydrogenated vegetable oil 1% soybean oil |
19%?hydrogenated vegetable oil 6% milk fat 4% palmitic acid |
Fatty acid profile, % total fat |
66% saturated 30% monounsaturated 4% polyunsaturated |
23% saturated 31% monounsaturated (cis) 12% polyunsaturated (cis) 34% trans |
43% saturated 27% monounsaturated (cis) 7% polyunsaturated (cis) 23% trans |
Sugars, % by weight | 34.5% sucrose | 22.4% sucrose | 34.5% sucrose |
Cholesterol, % by weight | 0.2 | 0 | 1.25 |
Modifications | TD.96121?1.25% cholesterol TD.120528?Increased sucrose, 1.25% cholesterol |
TD.120330?0.2% cholesterol TD.130885?0.2% cholesterol, 27% sucrose |
TD.140154?adds customer supplied palmitic acid |
For high fat diet options to induce uncomplicated NAFLD see our?Diet Induced Obesity page.
Diet options for inducing more severe hepatic NAFLD/NASH without obesity or metabolic syndrome | |||
Diet features | High Fat, Cholesterol & Cholate | Methionine/choline deficient (MCD) | |
Product Code | TD.02028 | TD.90262 | |
Fat, % Kcal | 42 | 22 | |
Fat Sources, % by weight |
21% milk fat | 10% corn oil | |
Fatty acid profile, % total fat |
66% saturated 30% monounsaturated 4% polyunsaturated |
14% saturated 28% monounsaturated 58% polyunsaturated |
|
Sugars, % by weight | 33.3% sucrose | 46% sucrose | |
Cholesterol, % by weight | 1.25 | 0 | |
Cholate Source, % by weight | 0.5 | 0 | |
Related diets | TD.09237?15% milk fat, 1% cholesterol TD.88051?Hybrid version |
TD.94149?MCD control diet |
Diets inducing obesity, metabolic syndrome and mild NAFLD/NASH
Western and Fast Food diets with milkfat and cholesterol
Western or fast food style diets fed to induce NASH with metabolic syndrome contain 40 – 45% kcal from milkfat (a fat source high in palmitate) with added cholesterol (0.15 – 2%) and are high in sucrose (>30%). Dietary palmitate and cholesterol have both previously been associated with the progression from simple steatosis to NASH.
Examples:
- TD.88137?? ? ? Adjusted Calories Diet (42% from fat)
- TD.96121?? ? ? 21% MF, 1.25% Chol. Diet
- TD.120528? ? ?42% Kcal/Fat Diet (Incr. Sucrose, 1.25% Chol.)
Research use:
These diets can induce obesity, metabolic syndrome, and simple steatosis within nine weeks of feeding. Increased hepatic inflammation has been observed after 12 weeks of feeding. NASH typically requires longer feeding with fibrosis developing within nine months and late stage fibrosis including hepatic ballooning occurring after 14 – 20 months of feeding. Increasing dietary sucrose (~41%) and cholesterol (~1.25%) accelerates the NASH phenotype with steatosis, inflammation and hepatocyte ballooning observed within 12 weeks. In addition to feeding a high fat diet, providing a glucose/fructose mixture in the drinking water may further promote NASH development.
Select References:
Charlton, M., et al., Fast food diet mouse: novel small animal model of NASH with ballooning, progressive fibrosis, and high physiological fidelity to the human condition. Am J Physiol Gastrointest Liver Physiol, 2011. 301(5): p. G825-34.?http://www.ncbi.nlm.nih.gov/pubmed/21836057
Gores, G., Charlton M, Krishnan A, Viker K, Sanderson S, Cazanave S, McConico A, Masuoko H. Am J Physiol Gastrointest Liver Physiol, 2015. 308: p. G159.?http://ajpgi.physiology.org/content/308/2/G159
Li, Z.Z., et al., Hepatic lipid partitioning and liver damage in nonalcoholic fatty liver disease: role of stearoyl-CoA desaturase. J Biol Chem, 2009. 284(9): p. 5637-44.?http://www.ncbi.nlm.nih.gov/pubmed/19119140
Ioannou, G.N., et al., Hepatic cholesterol crystals and crown-like structures distinguish NASH from simple steatosis. J Lipid Res, 2009. 54(5): p. 1326-34.?http://www.ncbi.nlm.nih.gov/pubmed/23417738
Alkhouri, N., et al., Adipocyte apoptosis, a link between obesity, insulin resistance, and hepatic steatosis. J Biol Chem, 2010. 285(5): p. 3428-38.?http://www.ncbi.nlm.nih.gov/pubmed/19940134
Dixon, L.J., et al., Caspase-1 as a central regulator of high fat diet-induced non-alcoholic steatohepatitis. PLoS One, 2013. 8(2): p. e56100.?http://www.ncbi.nlm.nih.gov/pubmed/23409132
DeLeve, L.D., et al., Prevention of hepatic fibrosis in a murine model of metabolic syndrome with nonalcoholic steatohepatitis. Am J Pathol, 2008. 173(4): p. 993-1001.?http://www.ncbi.nlm.nih.gov/pubmed/18772330
VanSaun, M.N., et al., High fat diet induced hepatic steatosis establishes a permissive microenvironment for colorectal metastases and promotes primary dysplasia in a murine model. Am J Pathol, 2009. 175(1): p. 355-64.?http://www.ncbi.nlm.nih.gov/pubmed/19541928
Asgharpour, A., et al., A diet-induced animal model of non-alcoholic fatty liver disease and hepatocellular cancer. J Hepatol, 2016. 65(3): p. 579-88.?http://www.ncbi.nlm.nih.gov/pubmed/27261415
Tetri, L.H., et al., Severe NAFLD with hepatic necroinflammatory changes in mice fed trans fats and a high-fructose corn syrup equivalent. Am J Physiol Gastrointest Liver Physiol, 2008. 295(5): p. G987-95.?http://www.ncbi.nlm.nih.gov/pubmed/18772365
Tsuchida, T., et al., A simple diet-and chemical-induced murine NASH model with rapid progression of steatohepatitis, fibrosis and liver cancer. Journal of hepatology, 2018. 69(2):385-395.?https://www.ncbi.nlm.nih.gov/pubmed/29572095
The ALIOS model: western diet with trans-fat
The American Lifestyle-Induced Obesity Syndrome (ALIOS) model involves feeding the “American fast food” diet high in trans-fats and sugar. Dietary trans-fats from hydrogenated vegetable shortening (HVO) are associated with increased insulin resistance and hepatic inflammation in rodent NASH models. In addition to diet, a glucose/fructose solution is added to the drinking water and sedentary behavior promoted by removing the overhead cage feeders in this model.
Examples:
- TD.06303?? ? ??22% HVO Diet
- TD.120330?? ??22% HVO + 0.2% Cholesterol Diet
- TD.130885?? ??ALIOS with Added Sugar
Research use:
The ALIOS model develops obesity with insulin resistance, elevated ALT levels, and steatosis within 16 weeks. Increased inflammation and early development of fibrosis have been observed at 6 months. Severe steatosis with fibrosis and inflammation develops within 12 months of feeding with 50% of the mice reportedly developing hepatic neoplasms. Adding cholesterol (0.2%) to the American Fast Food diet may accelerate NASH phenotype development.
Select References:
Koppe, S.W., et al., Trans fat feeding results in higher serum alanine aminotransferase and increased insulin resistance compared with a standard murine high-fat diet. Am J Physiol Gastrointest Liver Physiol, 2009. 297(2): p. G378-84.?http://www.ncbi.nlm.nih.gov/pubmed/19541924
Tetri, L.H., et al., Severe NAFLD with hepatic necroinflammatory changes in mice fed trans fats and a high-fructose corn syrup equivalent. Am J Physiol Gastrointest Liver Physiol, 2008. 295(5): p. G987-95.?http://www.ncbi.nlm.nih.gov/pubmed/18772365
Mells, J.E., et al., Glp-1 analog, liraglutide, ameliorates hepatic steatosis and cardiac hypertrophy in C57BL/6J mice fed a Western diet. Am J Physiol Gastrointest Liver Physiol, 2012. 302(2): p. G225-35.?http://www.ncbi.nlm.nih.gov/pubmed/22038829
Dowman, J.K, et al., Development of hepatocellular carcinoma in a murine model of nonalcoholic steatohepatitis induced by use of a high-fat/fructose diet and sedentary lifestyle. Am J Pathol, 2014. 184(5):1550-1561.?https://www.ncbi.nlm.nih.gov/pubmed/24650559?
Mells, J.E., et al., Saturated fat and cholesterol are critical to inducing murine metabolic syndrome with robust nonalcoholic steatohepatitis. J Nutr Biochem, 2014. 26(3): p. 285-92.?http://www.ncbi.nlm.nih.gov/pubmed/25577467
FPC diet: fructose, palmitate, cholesterol and trans-fat diet
The Fructose, Palmitate, Cholesterol and Trans-Fat (FPC) diet is a recent NASH diet that includes Western and ALIOS model diets to achieve both metabolic and hepatic NASH features within an accelerated time frame. Key features of the FPC diet include 1) a lower Met content than typical rodent diets by decreasing total protein without supplementing sulfur amino acids; 2) choline supplementation is lower than typical but is not considered deficient; 3) high in sucrose (~34% by weight); 4) 1.25% cholesterol; 5) 52% kcal from fat with fat sources including milkfat fat, palmitic acid and hydrogenated vegetable shortening to provide trans-fats. Like the ALIOS model, the FPC model also provides a glucose/fructose solution to the drinking water.
Examples:
- TD.160785?? ??52 kcal/Fat Diet (C16:0, HVO, AMF, Choline/Met)
Research use:
Male C57BL/6J mice fed the FPC diet and provided a glucose/fructose drinking solution developed insulin resistance and NAFLD with inflammation, hepatocyte death, and fibrosis within 16 weeks.
Select References:
Wang, X., et al., Hepatocyte TAZ/WWTR1 promotes inflammation and fibrosis in nonalcoholic steatohepatitis. Cell Metab, 2016. 24(6): p. 848-62.?https://www.ncbi.nlm.nih.gov/pubmed/28068223??
Zhu, C., et al., Hepatocyte Notch activation induces liver fibrosis in nonalcoholic steatohepatitis. Sci Transl Med, 2018. 10(468).?https://www.ncbi.nlm.nih.gov/pubmed/30463916
High fat diets
Common diets to induce obesity (DIO) can be fed to induce uncomplicated NAFLD. These high fat diets typically contain 40–60% kcal from fat without supplemented cholesterol or cholate. Simple sugars such as sucrose or fructose can also be supplemented via diet or water to progress the fatty liver phenotype. Diets can be in pellet or powder/dough form depending on the formula. Some models require limited physical activity and in those cases diets can be fed inside the cage. For more information see our?Diet Induced Obesity?page.
Examples:
- TD.08811?? ? ??45%kcal Fat Diet (21% MF, 2% SBO)
- TD.06414?? ? ??Adjusted Calories Diet (60/Fat)
Research use:
In susceptible rodent models, high fat diets are commonly used to induce NAFLD with obesity and insulin resistance common metabolic features associated with NASH in humans. However, the degree of NASH pathology (steatosis, inflammation, and fibrosis) is limited or mild and varies depending on the animal model, length of feeding, and dietary components.
Diets to induce severe hepatic NAFLD/NASH without obesity or metabolic
COLLAPSE ALL TABS
Atherogenic diets high in fat, cholesterol, and cholate
Originally formulated to induce mild atherosclerosis in wild-type rodents, high fat diets containing added cholesterol (1 – 1.25%) and cholate (0.5% as sodium cholate or cholic acid) have also been useful in inducing NASH. This diet option includes purified “Western” style diets with increased cholesterol and cholate and also hybrid diets. Hybrid diets were originally developed by Beverly Paigen and colleagues by mixing a natural ingredient mouse diet in a 3:1 ratio with a concentrated purified diet (containing 5% cholesterol and 2% sodium cholate) resulting in a diet containing ~15.8% fat, 1.25% cholesterol, and 0.5% sodium cholate. Although a less refined approach, the hybrid diet is associated with increased gallstone formation and liver damage as compared to similar purified diets.
Examples:
- TD.02028?? ? ??Atherogenic Rodent Diet
- TD.88051?? ? ??Cocoa Butter Diet and Purina Mouse Chow
- TD.09237?? ? ??15% AMF Diet (1% Chol, 0.5% NaChol)
Research use:
Atherogenic diets are able to induce varied degrees of NASH with increased hepatic inflammation with early fibrosis observed after ten weeks of feeding. However, the metabolic profile typical in human NASH (obesity with insulin resistance) is not recapitulated in this model with animals typically maintaining similar body weights as control fed groups without the development of metabolic syndrome.
Select References:
Nishina, P.M., J. Verstuyft, and B. Paigen, Synthetic low and high fat diets for the study of atherosclerosis in the mouse. J Lipid Res, 1990. 31(5): p. 859-69.?http://www.ncbi.nlm.nih.gov/pubmed/2380634
Kamari, Y., et al., Lack of interleukin-1alpha or interleukin-1beta inhibits transformation of steatosis to steatohepatitis and liver fibrosis in hypercholesterolemic mice. J Hepatol, 2011. 55(5): p. 1086-94.?http://www.ncbi.nlm.nih.gov/pubmed/21354232
Kim, D.G., et al., Non-alcoholic fatty liver disease induces signs of Alzheimer’s disease (AD) in wild-type mice and accelerates pathological signs of AD in an AD model. J Neuroinflammation, 2016. 13: p. 1.?http://www.ncbi.nlm.nih.gov/pubmed/26728181
Madrigal-Perez, V.M., et al., Preclinical analysis of nonsteroidal anti-inflammatory drug usefulness for the simultaneous prevention of steatohepatitis, atherosclerosis and hyperlipidemia. Int J Clin Exp Med, 2015. 8(12): p. 22477-83.?http://www.ncbi.nlm.nih.gov/pubmed/26885230
Savransky, V., et al., Chronic intermittent hypoxia causes hepatitis in a mouse model of diet-induced fatty liver. Am J Physiol Gastrointest Liver Physiol, 2007. 293(4): p. G871-7.?http://www.ncbi.nlm.nih.gov/pubmed/17690174
Methionine/choline deficient (MCD) diets
Methionine and choline deficient (MCD) diets are amino acid defined rodent diets deficient in methionine and choline, high in sucrose (>40% by weight) with ~10% corn oil by weight. Methionine and choline deficiency decreases fat oxidation and export of fat from the liver. Dietary sucrose is necessary for hepatic lipid accumulation and oxidation. The polyunsaturated fat in corn oil promotes hepatic lipid oxidation.
Example:
- TD.90262?? ? ??Methionine/Choline Deficient Diet
Control:
- TD.94149?? ? ??Amino Acid Control Diet
Research use:
Steatosis, increased serum alanine aminotransferase (ALT), inflammation, and hepatic fat oxidation has been observed within three weeks of feeding the MCD diet with fibrosis development after six weeks. This dietary model does not produce metabolic syndrome (an aspect of NASH in human models) and progressive weight loss (up to 40%) is associated with the MCD diet feeding.
蛋氨酸/膽堿缺乏癥(MCD)日糧
蛋氨酸和膽堿缺乏(MCD)飼料是一種氨基酸定義的嚙齒動物飼料,缺乏蛋氨酸和膽堿,蔗糖含量高(體重>40%),玉米油含量約10%。蛋氨酸和膽堿缺乏減少脂肪氧化和從肝臟輸出脂肪。日糧蔗糖對肝臟脂質(zhì)的積累和氧化是必需的。玉米油中的多不飽和脂肪促進肝臟脂質(zhì)氧化。
例子:TD.90262 蛋氨酸/膽堿缺乏癥飲食
管制:TD.94149 氨基酸控制飲食
研究用途:
觀察到脂肪變性、血清丙氨酸轉氨酶(ALT)升高、炎癥和肝脂肪氧化反應。這種飲食模式不會產(chǎn)生代謝綜合癥(在人類模型中是NASH的一個方面)和累進性減肥(高達40%)與MCD飲食喂養(yǎng)有關。
Select References:
Pickens, M.K., et al., Dietary sucrose is essential to the development of liver injury in the MCD model of steatohepatitis. J Lipid Res, 2009. 50(10):2072-82.??http://www.ncbi.nlm.nih.gov/pubmed/19295183
Li, Z.Z., et al., Hepatic lipid partitioning and liver damage in nonalcoholic fatty liver disease: role of stearoyl-CoA desaturase. J Biol Chem, 2009. 284(9): p. 5637-44.?http://www.ncbi.nlm.nih.gov/pubmed/19119140
Lee, G.S., et al., Polyunsaturated fat in the methionine-choline-deficient diet influences hepatic inflammation but not hepatocellular injury. J Lipid Res, 2007. 48(8): p. 1885-96.?http://www.ncbi.nlm.nih.gov/pubmed/17526933
Vetelainen, R., A. van Vliet, and T.M. van Gulik, Essential pathogenic and metabolic differences in steatosis induced by choline or methione-choline deficient diets in a rat model. J Gastroenterol Hepatol, 2007. 22(9): p. 1526-33.?http://www.ncbi.nlm.nih.gov/pubmed/17716355
Leclercq, I.A., et al., Intrahepatic insulin resistance in a murine model of steatohepatitis: effect of PPARgamma agonist pioglitazone. Lab Invest, 2007. 87(1): p. 56-65.?http://www.ncbi.nlm.nih.gov/pubmed/17075577
Kashireddy, P.R. and M.S. Rao, Sex differences in choline-deficient diet-induced steatohepatitis in mice. Exp Biol Med (Maywood), 2004. 229(2): p. 158-62.?http://www.ncbi.nlm.nih.gov/pubmed/14734794
Dixon, L.J., et al., Caspase-1-mediated regulation of fibrogenesis in diet-induced steatohepatitis. Lab Invest, 2012. 92(5): p. 713-23.?http://www.ncbi.nlm.nih.gov/pubmed/22411067
Emerging NASH models
Dietary models of NAFLD/NASH continue to evolve with the goal of more accurately recapitulating both the metabolic and hepatic symptoms of human disease. Commonly researchers are studying the synergistic effects of various NASH dietary features to accelerate progression of the model and severity of liver disease.
A Teklad nutritionist can work with you to formulate new diets in order to investigate novel dietary models of NAFLD/NASH.
Control diets
The choice of control diet is dependent on the specific research goal. Many researchers choose to compare their NAFLD/NASH diet-fed animals to animals fed a natural ingredient, grain-based diet (also referred to as standard diet or chow). These diets differ in the source and level of nutrients as well as in the presence of non-nutritive factors (such as phytates or phytoestrogens).
Depending on what your main comparisons are, it may be suitable to have a grain-based diet as your control/reference group. However, making such comparisons limits inferences to dietary patterns versus a specific dietary component. In some cases, such as those studies feeding amino acid defined diets like the MCD model, a matched control diet is recommended given the very different formulations and protein sources of grain-based diets.
When making inferences about specific nutrients within the diet an ingredient matched, low fat control diet may be necessary. There are many options with different levels and types of fat in addition to different types of carbohydrate ranging from sucrose (highly refined and digestible) to corn starch (refined, but more complex) to resistant starch (refined, but not fully digestible).
A very basic purified control diet would be AIN-93M?TD.94048?or AIN-93G?TD.94045. AIN-93 diets have a moderate amount of sucrose at ~10% with fat from soybean oil providing a healthy fatty acid profile.
Contact a nutritionist?for an additional information and control diet recommendations.
對照日糧
控制飲食的選擇取決于具體的研究目標。許多研究人員選擇比較他們的NAFLD/納什飲食喂養(yǎng)的動物和喂養(yǎng)一種天然成分的動物,谷物為基礎的飲食(也稱為標準飲食或周食)。這些飲食在營養(yǎng)來源和水平以及非營養(yǎng)因素(如植酸鹽或植物雌激素)存在的情況下存在差異。
根據(jù)您的主要比較,它可能適合作為您的對照/參考組谷物基礎的飲食。然而,這樣的比較限制了對飲食模式和特定飲食成分的推斷。在某些情況下,如那些研究喂食氨基酸定義的飲食,如mcd模型,建議一個匹配的對照飲食,考慮到非常不同的配方和蛋白質(zhì)來源的谷物為基礎的飲食。
當對飲食中的特定營養(yǎng)成分做出相應的推斷時,低脂控制飲食可能是必要的。除了不同類型的碳水化合物外,還有許多不同水平和類型的脂肪,從蔗糖(高精制和可消化)到玉米淀粉(精制,但更復雜),再到抗性淀粉(精制,但不能完全消化)。
一種非常基本的純正控制飲食將是-9300萬。TD.94048或者是93g TD.94045。AIN-93日糧中含有適量的蔗糖~10%,大豆油中的脂肪提供了健康的脂肪酸譜。
Need more information? A Teklad nutritionist will work with you to determine if existing diets will meet your needs or formulate new diets to help you investigate novel dietary models of NAFLD/NASH.?Contact us?for a diet consultation.